Cancer antigens, also known as tumor-associated antigens (TAAs) or tumor-specific antigens (TSAs), can be classified based on their origin and specificity. TSAs are unique to cancer cells and not found on normal cells, making them ideal targets for immunotherapy. TAAs, on the other hand, might be present in normal cells but are overexpressed in cancerous cells.
